Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
1044
First IPO Date
December 02, 2020
| Name | Title | Pay | Year Born |
| Chen Huang | Marketing Manager | 0 | 1975 |
| Feng Xu | Deputy GM & Director | 0 | 1965 |
| Huayong Zhou | Deputy Director of R&D | 0 | 1984 |
| Huibing Luo | Chief Chemistry Officer | 0 | 1974 |
| Jie Hu | Vice Chairman & Deputy GM | 0 | 1975 |
| Jinhao Du | Chairman of the Board & GM | 0 | 1954 |
| Lin Wang | Financial Director | 0 | 1983 |
| Huafeng Shan | Chief Quality Officer | 0 | 1974 |
| Shuo Li | Board Secretary | 0 | 1990 |
| Quan Gan | Accounting Supervisor | 0 | N/A |
Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese enterprise dedicated to the innovation and development of medicinal products. Headquartered in Shanghai, the company focuses its efforts on creating therapeutic agents specifically for the treatment of various tumor and cancer-related conditions.